British Columbian researchers are teaming up with Harvard researchers to develop nanotechnology as a way to combat opioid addiction.
UBC researchers are exploring ways to detect addiction risk factors based on markers in a person’s microbiome.
The new nanotechnology would use proteins in a patient’s blood plasma to determine how predisposed they are to addiction.
This information could be helpful to doctors as they determine what to prescribe patients.
The technology could make a dent in the nearly 14 hundred illicit drug overdose deaths in BC alone last year.